1型糖尿病新兴成年人的COVID-19疫苗接种率与态度
研究纳入随机对照试验中97名即将离开儿科照护的1型糖尿病年轻成人,在2021年2月至2023年6月报告COVID-19疫苗接种情况,70.1%报告至少接种一剂,人口学与医学特征与接种状态无显著关联,未接种原因包括怀疑、恐惧、外部因素和漠不关心。
要点
- 97名1型糖尿病年轻成人中70.1%报告至少接种一剂COVID-19疫苗。
- 人口学与医学特征与接种状态均无显著关联(p≥0.05)。
- 未接种原因主题包括怀疑、恐惧、外部因素和漠不关心。
核心结论
- 在1型糖尿病年轻成人中,COVID-19疫苗接种率低于公共卫生目标。
- 作者认为,处理对疫苗影响1型糖尿病的恐惧、对疫苗研发与有效性的怀疑以及其他外部因素,可能有助于临床医生与考虑接种的年轻成人开启对话。
- 作者提出需要进一步调查该脆弱人群对其他预防保健措施的态度。
研究设计与样本
- 参与者来自一项针对1型糖尿病年轻成人过渡干预的随机对照试验,在基线(2021年2月至2023年6月)报告COVID-19疫苗接种情况。
- 报告接种状态的参与者共97名,研究同时报告人口学与医学特征,并询问未接种者原因,从定性回答中归纳主题。
- 临床试验注册号为ClinicalTrials.gov NCT04247620。
主要发现
- 97名报告接种状态的参与者中,70.1%报告至少接种一剂COVID-19疫苗。
- 人口学或医学特征与接种状态均无显著关联(p≥0.05)。
- 未接种COVID-19疫苗的原因主题包括怀疑、恐惧、外部因素和漠不关心。
局限性
- 作者提出需要进一步调查该脆弱人群对其他预防保健措施的态度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Adolescents and young adults have lower uptake of vaccines for preventable diseases than children and older adults. Young adults with type 1 diabetes (T1D) are at risk of complications from many vaccine-preventable illnesses. Given the elevated health risks of SARS-COV-2 infection for people with T1D, it is important to understand COVID-19 vaccination rates and attitudes. We explored vaccine uptake and characterized self-reported reasons for declining vaccination in a cohort of young adults with T1D as they were leaving pediatric care during the COVID-19 pandemic. METHODS: Participants enrolled in a randomized controlled trial of a transition intervention for young adults with T1D reported COVID-19 vaccination at baseline (2/2021-6/2023). We report rates of COVID-19 vaccination in addition to demographic and medical characteristics. Participants who did not receive vaccination were asked to note the reason(s). From these qualitative responses we identified themes. RESULTS: Of the n = 97 participants reporting vaccination status, 70.1 % reported receiving at least one COVID-19 vaccine. No demographic or medical characteristics were significantly associated with vaccination status (p ≥ 0.05). Themes of reasons for not receiving the COVID-19 vaccination included Doubt, Fear, External Factors, and Indifference. DISCUSSION: In young adults with T1D, COVID-19 vaccine uptake is below public health targets. Addressing fears about vaccine-related effects on T1D, doubts surrounding vaccine development and efficacy, and other external factors influencing vaccination decisions may be helpful in initiating a dialogue between clinicians and young adults considering vaccination. Further investigation into attitudes about other preventative care measures in this vulnerable population is needed. Clinical trial registry site and number: ClinicalTrials.gov ID Number - NCT04247620.
引用
- Macke CA, Carreon SA, Desai KR, et al. COVID-19 vaccine uptake and attitudes in emerging adults with type 1 diabetes. Vaccine. 2025. PMID: 40750525. doi:10.1016/j.vaccine.2025.127083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。